These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2157762)

  • 1. Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.
    LeClerc C; Martineau P; Van der Werf S; Deriaud E; Duplay P; Hofnung M
    J Immunol; 1990 Apr; 144(8):3174-82. PubMed ID: 2157762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics.
    Leclerc C; Charbit A; Martineau P; Deriaud E; Hofnung M
    J Immunol; 1991 Nov; 147(10):3545-52. PubMed ID: 1719080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.
    Lo-Man R; Martineau P; Betton JM; Hofnung M; Leclerc C
    J Immunol; 1994 Jun; 152(12):5660-9. PubMed ID: 7515911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein.
    Martineau P; Leclerc C; Hofnung M
    Mol Immunol; 1996 Dec; 33(17-18):1345-58. PubMed ID: 9171894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular parameters controlling the immunogenicity of foreign B- or T-cell epitopes expressed by recombinant vectors.
    Leclerc C; Lo-Man R; Fayolle C; Charbit A; Clément JM; Martineau P; O'Callaghan D; Hofnung M
    Dev Biol Stand; 1994; 82():193-9. PubMed ID: 7525391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.
    Martineau P; Guillet JG; Leclerc C; Hofnung M
    Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope.
    Lo-Man R; Martineau P; Hofnung M; Leclerc C
    Eur J Immunol; 1993 Nov; 23(11):2998-3002. PubMed ID: 8223877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and immune response to foreign epitopes in bacteria. Perspectives for live vaccine development.
    Charbit A; Newton SM; Klebba PE; Clément JM; Fayolle C; Lo-Man R; Leclerc C; Hofnung M
    Behring Inst Mitt; 1997 Feb; (98):135-42. PubMed ID: 9382734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins.
    Charbit A; Martineau P; Ronco J; Leclerc C; Lo-Man R; Michel V; O'Callaghan D; Hofnung M
    Vaccine; 1993 Sep; 11(12):1221-8. PubMed ID: 8256503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant Escherichia coli heat-stable enterotoxin b (STb) fusion protein eliciting neutralizing antibodies.
    Dubreuil JD; Letellier A; Harel J
    FEMS Immunol Med Microbiol; 1996 Apr; 13(4):317-23. PubMed ID: 8739196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of viral B-cell epitopes inserted into two surface loops of the Escherichia coli K12 LamB protein and expressed in an attenuated aroA strain of Salmonella typhimurium.
    Wang J; Michel V; Leclerc C; Hofnung M; Charbit A
    Vaccine; 1999 Jan; 17(1):1-12. PubMed ID: 10078601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to hybrid maltose-binding proteins.
    O'Callaghan D; Martineau P; Fayolle C; Leclerc C; Guillet JG; Charbit A; Hofnung M
    Vaccine; 1993; 11(2):140-2. PubMed ID: 7679863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: first immunization results.
    Charbit A; Van der Werf S; Mimic V; Boulain JC; Girard M; Hofnung M
    Ann Inst Pasteur Microbiol; 1988; 139(1):45-58. PubMed ID: 2454645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles.
    Delpeyroux F; Chenciner N; Lim A; Malpièce Y; Blondel B; Crainic R; van der Werf S; Streeck RE
    Science; 1986 Jul; 233(4762):472-5. PubMed ID: 2425433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein.
    Lo-Man R; Martineau P; Manoury-Schwartz B; Hofnung M; Leclerc C
    Int Immunol; 1996 Aug; 8(8):1245-55. PubMed ID: 8918694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control by Ig genes of the responsiveness to a neutralization viral B cell epitope.
    Leclerc C; Martineau P; Charlot B; Delpeyroux F; van der Werf S; Hofnung M
    J Immunol; 1997 Apr; 158(7):3252-8. PubMed ID: 9120281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization.
    Leclerc C; Charbit A; Molla A; Hofnung M
    Vaccine; 1989 Jun; 7(3):242-8. PubMed ID: 2476894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria.
    Clarke BE; Brown AL; Grace KG; Hastings GZ; Brown F; Rowlands DJ; Francis MJ
    J Gen Virol; 1990 May; 71 ( Pt 5)():1109-17. PubMed ID: 1693163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of two epitopes of the preS2 region of hepatitis B virus on live recombinant bacteria.
    Charbit A; Sobczak E; Michel ML; Molla A; Tiollais P; Hofnung M
    J Immunol; 1987 Sep; 139(5):1658-64. PubMed ID: 2442253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein.
    Coëffier E; Clément JM; Cussac V; Khodaei-Boorane N; Jehanno M; Rojas M; Dridi A; Latour M; El Habib R; Barré-Sinoussi F; Hofnung M; Leclerc C
    Vaccine; 2000 Nov; 19(7-8):684-93. PubMed ID: 11115689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.